CSFZX
Price
$52.74
Change
-$0.21 (-0.40%)
Updated
May 22 closing price
Net Assets
1.94B
SREZX
Price
$13.02
Change
-$0.03 (-0.23%)
Updated
May 22 closing price
Net Assets
180.5M
Interact to see
Advertisement

CSFZX vs SREZX

Header iconCSFZX vs SREZX Comparison
Open Charts CSFZX vs SREZXBanner chart's image
Cohen & Steers Global Realty Z
Price$52.74
Change-$0.21 (-0.40%)
VolumeN/A
Net Assets1.94B
PGIM Select Real Estate Z
Price$13.02
Change-$0.03 (-0.23%)
VolumeN/A
Net Assets180.5M
CSFZX vs SREZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSFZX vs. SREZX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSFZX is a Hold and SREZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSFZX has more cash in the bank: 1.94B vs. SREZX (180M). CSFZX pays higher dividends than SREZX: CSFZX (2.74) vs SREZX (2.48). CSFZX was incepted earlier than SREZX: CSFZX (11 years) vs SREZX (11 years). SREZX (1.10) is less costly to investors than CSFZX (0.84). SREZX is a more actively managed with annual turnover of: 142.00 vs. CSFZX (67.00). CSFZX (0) and SREZX (0) have matching initial minimum investment requirements. SREZX annual gain was more profitable for investors over the last year : 8.00 vs. CSFZX (6.34). CSFZX return over 5 years is better than : 39.14 vs. SREZX (35.59).
CSFZXSREZXCSFZX / SREZX
Total Expense Ratio0.841.0679%
Annual Report Gross Expense Ratio0.841.1076%
Fund Existence11 years11 years-
Gain YTD3.3101.023324%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B180M1,079%
Annual Yield % from dividends2.742.48110%
Returns for 1 year6.348.0079%
Returns for 3 years2.276.7434%
Returns for 5 years39.1435.59110%
Returns for 10 years37.0651.3272%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOXA55.14N/A
N/A
Fox Corp
PPBT2.37N/A
N/A
Purple Biotech Ltd
PTGX45.82N/A
N/A
Protagonist Therapeutics
LASR13.45N/A
N/A
nLIGHT
XTNT0.69N/A
N/A
Xtant Medical Holdings